[HTML][HTML] Composite outcomes of drug-coated balloon using in left main bifurcation lesions: a systematic review

Y Cheng, C Yong, BT Huang… - Journal of Geriatric …, 2024 - pmc.ncbi.nlm.nih.gov
Background Left main coronary bifurcation lesions account for 50% of left main coronary
artery disease cases. Although a drug-coated balloon (DCB) has the advantages of …

Four‐Year Outcomes of Left Main Percutaneous Coronary Intervention with a Bioresorbable Scaffold in the Circumflex Ostium

A Erglis, I Narbute, D Sondore, S Jegere… - Journal of …, 2022 - Wiley Online Library
Objectives. The study aimed to investigate the long‐term outcomes of a double stent scaffold
strategy in patients with left main (LM) bifurcation lesions involving the ostium of the left …

[HTML][HTML] Major adverse cardiovascular events after implantation of absorb bioresorbable scaffold: One-year clinical outcomes

T Šobot, N Šobot, Z Bajić, N Ponorac, R Babić - Scripta Medica, 2021 - scindeks.ceon.rs
Background/Aim: Bioresorbable vascular scaffold (BVS) represents a novel generation of
intracoronary devices designed to be fully resorbed after healing of the stented lesion …

[PDF][PDF] Research Article Four-Year Outcomes of Left Main Percutaneous Coronary Intervention with a Bioresorbable Scaffold in the Circumflex Ostium

A Erglis, I Narbute, D Sondore, S Jegere, I Kumsars… - 2022 - academia.edu
Objectives. Te study aimed to investigate the long• term outcomes of a double stent scaffold
strategy in patients with left main (LM) bifurcation lesions involving the ostium of the left …